Company Description
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.
It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns.
It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand.
In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands.
Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis.
The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection.
Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
| Country | United States |
| Founded | 1981 |
| IPO Date | Aug 23, 1989 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,636 |
| CEO | Mikhael Nassif |
Contact Details
Address: 620 Lesher Place Lansing, Michigan 48912-1595 United States | |
| Phone | 517 372 9200 |
| Website | neogen.com |
Stock Details
| Ticker Symbol | NEOG |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| CIK Code | 0000711377 |
| CUSIP Number | 640491106 |
| ISIN Number | US6404911066 |
| Employer ID | 38-2367843 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Mikhael Nassif | Chief Executive Officer, President and Director |
| R. Bryan Riggsbee CPA | Chief Financial Officer and Senior Vice President |
| Jennifer Evans Stacey Esq., J.D. | Senior Vice President, Chief Legal and Compliance Officer and Board Secretary |
| Dr. Tamara A. Ranalli Ph.D. | Senior Vice President and GM of Global Food Safety |
| John Moylan | Vice President, Corporate Controller and Chief Accounting Officer |
| Dr. Jeremy Yarwood | Chief Scientific Officer |
| Sarah Demey | Administrative Manager |
| Kevin M. Burke | Chief Human Resources Officer |
| Joe Freels | Senior Vice President and Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 7, 2026 | 10-Q | Quarterly Report |
| Oct 7, 2026 | 8-K | Current Report |
| Oct 6, 2026 | 8-K | Current Report |
| Sep 28, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 21, 2026 | ARS | Filing |
| Aug 21, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 21, 2026 | DEF 14A | Other definitive proxy statements |
| Aug 7, 2026 | 8-K | Current Report |
| Jul 30, 2026 | 10-K | Annual Report |
| Jul 30, 2026 | 8-K | Current Report |